2019
22/11/2019 2019 AGM CEO's Speech
22/11/2019 2019 AGM Chairman's Address
19/11/2019 Mayne Pharma continues expansion of dermatology pipeline
13/11/2019 Mayne Pharma completes E4/DRSP transaction
23/10/2019 E4/DRSP contraceptive presented at EU gynecology conference
21/10/2019 Notice of Annual General Meeting/Proxy Form
21/10/2019 Retirement of Director
02/10/2019 Mayne Pharma signs 20-year license agreement for novel oral contraceptive in the US
27/08/2019 Mayne Pharma announces PBS listing of Kapanol® for chronic breathlessness
23/08/2019 FY19 Results Media Release
22/05/2019 FDA Approves Sorilux for Adolescent Plaque Psoriasis
14/05/2019 Mayne Pharma Market Update
22/02/2019 HY19 Results Media Release
19/02/2019 Mayne Pharma Announces New Chronic Breathlessness Indication for Kapanol® by TGA
13/02/2019 Mayne Pharma Launches Lexette™ (Halobetasol Propionate) Foam 0.05% in the US
30/01/2019 Mayne Pharma Tolsura (SUBA®-itraconazole) capsule now launched in the US